Metrovacesa S.A. (BME:MVC)
Spain · Delayed Price · Currency is EUR 10.64
+0.04 (0.38%)
Aug 21, 2026, 5:35 PM CET
Metrovacesa Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Property, Plant & Equipment | 258.46 | 248.71 | 244.01 | 243.47 | 242.65 | 418.64 |
Cash & Equivalents | 159.82 | 194.06 | 186.43 | 196.3 | 202.01 | 299.55 |
Accounts Receivable | 82 | 69.42 | 62.55 | 36.84 | 15.88 | 5.69 |
Other Receivables | 7.22 | 6.8 | 10.69 | 25.81 | 25.59 | 19.21 |
Investment In Debt and Equity Securities | 10.88 | 22.34 | 16.46 | 51.62 | 25.46 | 34.26 |
Loans Receivable Current | 7.27 | 7.08 | 6.71 | - | - | - |
Other Current Assets | 1,483 | 1,589 | 1,758 | 1,841 | 1,853 | 1,853 |
Deferred Long-Term Tax Assets | 70.33 | 70.63 | 79.22 | 75.98 | 79.61 | 84.33 |
Other Long-Term Assets | 52.19 | 49.5 | 49.15 | 61.43 | 69.73 | 62.06 |
Total Assets | 2,131 | 2,258 | 2,414 | 2,533 | 2,514 | 2,777 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Current Portion of Long-Term Debt | 120.57 | 145.67 | 101.17 | 159.16 | 45.38 | 66.69 |
Long-Term Debt | 234.16 | 253.71 | 248.34 | 233.63 | 273.15 | 287.44 |
Accounts Payable | 76.18 | 71.27 | 71.15 | 72.23 | 76.16 | 54.08 |
Accrued Expenses | 24.18 | 25.77 | 37.56 | 49.17 | 24.81 | 16.21 |
Current Income Taxes Payable | - | 0.28 | 8.14 | - | - | - |
Current Unearned Revenue | 245.14 | 211.41 | 207.92 | 197.57 | 180.24 | 161.84 |
Other Current Liabilities | 29.79 | 31.85 | 36.18 | 31.68 | 26.51 | 29 |
Long-Term Deferred Tax Liabilities | 15.69 | 13.88 | 10.72 | 8.29 | 7.58 | 7.1 |
Other Long-Term Liabilities | 54.14 | 54.79 | 50.87 | 50.04 | 45.5 | 39.08 |
Total Liabilities | 834.48 | 843.82 | 816.64 | 847.36 | 708.34 | 697.34 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,092 | 1,092 | 1,092 | 1,092 | 1,092 | 1,092 |
Additional Paid-In Capital | 376.25 | 512.72 | 752.21 | 856.8 | 956.82 | 1,208 |
Retained Earnings | -184.61 | -202.44 | -259.3 | -275.19 | -254.39 | -230.96 |
Treasury Stock | -0.43 | -1.43 | -1.17 | -1.67 | -2.56 | -2.7 |
Comprehensive Income & Other | 13.15 | 13.24 | 13.07 | 13.3 | 13.61 | 13.37 |
Total Common Equity | 1,296 | 1,414 | 1,597 | 1,685 | 1,806 | 2,080 |
Shareholders' Equity | 1,296 | 1,414 | 1,597 | 1,685 | 1,806 | 2,080 |
Total Liabilities & Equity | 2,131 | 2,258 | 2,414 | 2,533 | 2,514 | 2,777 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 389.35 | 434.56 | 394.11 | 438.39 | 347.53 | 390.03 |
Net Cash (Debt) | -229.53 | -240.5 | -207.68 | -242.09 | -145.51 | -90.48 |
Net Cash (Debt) Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.51 | -1.59 | -1.37 | -1.60 | -0.96 | -0.60 |
Filing Date Shares Outstanding | 151.65 | 151.55 | 151.39 | 151.51 | 151.43 | 151.45 |
Total Common Shares Outstanding | 151.65 | 151.55 | 151.39 | 151.51 | 151.43 | 151.45 |
Book Value Per Share | 8.55 | 9.33 | 10.55 | 11.12 | 11.92 | 13.73 |
Tangible Book Value | 1,296 | 1,414 | 1,597 | 1,685 | 1,806 | 2,080 |
Tangible Book Value Per Share | 8.55 | 9.33 | 10.55 | 11.12 | 11.92 | 13.73 |